NO975136D0 - Farmasöytisk blanding omfattende Lactobacillus plantarum og arginin - Google Patents

Farmasöytisk blanding omfattende Lactobacillus plantarum og arginin

Info

Publication number
NO975136D0
NO975136D0 NO975136A NO975136A NO975136D0 NO 975136 D0 NO975136 D0 NO 975136D0 NO 975136 A NO975136 A NO 975136A NO 975136 A NO975136 A NO 975136A NO 975136 D0 NO975136 D0 NO 975136D0
Authority
NO
Norway
Prior art keywords
arginine
pharmaceutical composition
lactobacillus plantarum
composition
curative
Prior art date
Application number
NO975136A
Other languages
English (en)
Other versions
NO317668B1 (no
NO975136L (no
Inventor
Diya Adawi
Bengt Jeppson
Goeran Molin
Original Assignee
Probi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probi Ab filed Critical Probi Ab
Publication of NO975136L publication Critical patent/NO975136L/no
Publication of NO975136D0 publication Critical patent/NO975136D0/no
Publication of NO317668B1 publication Critical patent/NO317668B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO19975136A 1995-05-09 1997-11-07 Farmasoytisk blanding omfattende Lactobacillus plantarum og arginin, samt anvendelse derav NO317668B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9501719A SE9501719D0 (sv) 1995-05-09 1995-05-09 Pharmaceutical composition
PCT/SE1996/000603 WO1996035440A1 (en) 1995-05-09 1996-05-08 Pharmaceutical composition comprising lactobacillus plantarum and arginine

Publications (3)

Publication Number Publication Date
NO975136L NO975136L (no) 1997-11-07
NO975136D0 true NO975136D0 (no) 1997-11-07
NO317668B1 NO317668B1 (no) 2004-11-29

Family

ID=20398250

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19975136A NO317668B1 (no) 1995-05-09 1997-11-07 Farmasoytisk blanding omfattende Lactobacillus plantarum og arginin, samt anvendelse derav

Country Status (16)

Country Link
EP (1) EP0825869B1 (no)
JP (1) JP4058560B2 (no)
KR (1) KR19990008403A (no)
CN (1) CN1152678C (no)
AT (1) ATE221783T1 (no)
AU (1) AU704886B2 (no)
BR (1) BR9608284A (no)
CA (1) CA2220498A1 (no)
DE (2) DE825869T1 (no)
EE (1) EE03597B1 (no)
ES (1) ES2112818T3 (no)
GR (1) GR980300028T1 (no)
NO (1) NO317668B1 (no)
PL (1) PL184603B1 (no)
SE (1) SE9501719D0 (no)
WO (1) WO1996035440A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100376954B1 (ko) * 1995-07-31 2003-07-18 프로비 에이비 장에서집락화하는유산간균
BR0109496A (pt) 2000-03-24 2002-12-10 Nestle Sa Uso de bactéria do ácido láctico para o tratamento de peritonite
KR100585391B1 (ko) * 2002-01-24 2006-06-01 주식회사 프로바이오닉 돼지 전염성위장염 (TGE) 코로나바이러스 및 유해 미생물 억제 활성을 갖는 신규 락토바실러스 프란타럼 Probio-38 및 이를 함유하는 생균활성제
SE527555C2 (sv) * 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
TW200536552A (en) * 2004-03-31 2005-11-16 Calpis Co Ltd Hepatopathy preventive or inhibitory agents and functional food for preventing or inhibiting hepatopathy
KR100592717B1 (ko) * 2004-11-20 2006-06-26 주식회사 알엔에이 간 손상 보호 및 예방에 유용한 활성을 갖는 조성물
CN1322111C (zh) * 2004-12-17 2007-06-20 上海交大昂立股份有限公司 一种植物乳杆菌
CN100337653C (zh) * 2004-12-21 2007-09-19 上海交大昂立股份有限公司 一种含有植物乳杆菌的组合物
DK2277524T3 (en) 2005-09-28 2016-02-08 Nordisk Rebalance As Treatment of IBS using both probiotic bacteria and fermented cereal as treatment effectors
JP5413819B2 (ja) * 2008-02-08 2014-02-12 国立大学法人広島大学 肝機能改善剤およびその製造用ツール、ならびにこれらの利用
KR101075557B1 (ko) * 2008-12-03 2011-10-20 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
WO2010064434A1 (ja) * 2008-12-03 2010-06-10 国立大学法人広島大学 肝機能障害予防剤
KR101075558B1 (ko) * 2008-12-03 2011-10-20 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
KR101255050B1 (ko) 2009-07-14 2013-04-16 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
KR101486999B1 (ko) * 2009-07-22 2015-01-28 씨제이제일제당 주식회사 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
CN102618456B (zh) * 2012-02-28 2013-08-21 江南大学 一种能够缓解慢性酒精性肝损伤的鼠李糖乳杆菌及其用途
TWI463986B (zh) * 2012-08-29 2014-12-11 Univ China Medical 胚芽乳酸桿菌ｃｍｕ９９５菌株之新用途
BR112019021742A2 (pt) 2017-04-17 2020-05-05 Univ Chicago composição, sistema, composição farmacêutica, composição alimentícia ou nutracêutica, método e uso da composição
WO2023104887A1 (en) * 2021-12-09 2023-06-15 Société des Produits Nestlé S.A. Lactobacillus acidophilus to increase agmatine production by microbiota

Also Published As

Publication number Publication date
CA2220498A1 (en) 1996-11-14
CN1190346A (zh) 1998-08-12
GR980300028T1 (en) 1998-04-30
ATE221783T1 (de) 2002-08-15
DE825869T1 (de) 1998-07-16
PL323320A1 (en) 1998-03-16
ES2112818T1 (es) 1998-04-16
BR9608284A (pt) 1999-06-08
NO317668B1 (no) 2004-11-29
EP0825869A1 (en) 1998-03-04
NO975136L (no) 1997-11-07
DE69622855D1 (de) 2002-09-12
EP0825869B1 (en) 2002-08-07
DE69622855T2 (de) 2003-04-10
WO1996035440A1 (en) 1996-11-14
SE9501719D0 (sv) 1995-05-09
EE03597B1 (et) 2002-02-15
PL184603B1 (pl) 2002-11-29
AU704886B2 (en) 1999-05-06
ES2112818T3 (es) 2003-02-16
CN1152678C (zh) 2004-06-09
KR19990008403A (ko) 1999-01-25
AU5784696A (en) 1996-11-29
JP4058560B2 (ja) 2008-03-12
JPH11504936A (ja) 1999-05-11
EE9700269A (et) 1998-04-15

Similar Documents

Publication Publication Date Title
NO975136L (no) Farmasöytisk blanding omfattende Lactobacillus plantarum og arginin
HUP0200206A2 (hu) Tejsavbaktérium-törzsek hasmenés megelőzésére
SE9702083D0 (sv) Farmaceutisk beredning för bekämpning av patogena tarmbakterier
DE69839993D1 (de) Probiotisches milchsäurebakterium zur behandlung bakterieller infektionen in zusammenhang mit sids
HU9603251D0 (en) Lactobacillus strains of human origin, their compositions and uses thereof
TR200101699T2 (tr) Urogenital enfeksiyonların önlenmesi ve tedavisi için ağızdan lactobakilus uygulaması
HUP0200205A2 (hu) Tejsavbaktérium-törzsek hasmenés megelőzésére
HUP0203185A2 (hu) Vérnyomáscsökkentő di- és tripeptideket termelő Lactobacillus helveticus
NO931085D0 (no) Tarmkanal-koloniserende basiller
BR0313185A (pt) Probióticos para funções neuromusculares intestinais
HUP9901707A2 (hu) Gasztrointesztinális rendellenességek megelőzésére és kezelésére szolgáló gyógyászati, és diétás készítmények
ES2074698T3 (es) Composicion oral para el tratamiento de enfermedades intestinales inflamatorias.
WO2002083879A3 (en) Immunotherapy based on dendritic cells
WO1998035658A3 (de) Verwendung von 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzochinon
ZA947894B (en) Compounds for medicinal use
JPS6483025A (en) Blended preparation of drug-resistant live bacterium agent for controlling intestinal function and antibacterial agent
RU2072692C1 (ru) Штамм бактерий lactobacillus helveticus, обладающий способностью снижать уровень холестерина в крови и используемый для получения препаратов и продуктов питания для профилактики и лечения гиперхолестеринемий
AU3439897A (en) Pharmaceutical formulations containing colostrum and their use
AU4630700A (en) Bacteria strain lactobacillus acidophilus N.V EP 317/402 (narine) AAA used in the production of preparations and of dietetic, therapeutic and prophylactic products for treating dysbacteriosis and the consequences thereof
Garg Role of omeprazole in prevention and treatment of postendoscopic variceal sclerotherapy esophageal complications
UA30011A (uk) Спосіб профілактики гострих стресових уражень шлунково-кишкового тракту після порожнинних оперативних втручань
UA31364A (uk) Спосіб лікування дисбактеріозу кишечнику у хворих на гострий пієлонефрит
IT1274733B (it) Ceppo del genere lactobacillus di origine umana e suoi usi
BG49408A1 (en) Medicationad premix
UA10219A (uk) Спосіб лікування туберкульозу легень

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application